Englewood Lab, Inc. (KOSDAQ:950140)
South Korea · Delayed Price · Currency is KRW 12,330
-250 (-1.99%)
At close: Dec 5, 2025
Englewood Lab Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 25,119 | 19,628 | 20,742 | 7,265 | 14,997 | 3,082 | Upgrade |
Depreciation & Amortization | 5,554 | 5,116 | 4,394 | 4,349 | 4,304 | 4,438 | Upgrade |
Loss (Gain) From Sale of Assets | -10.79 | -10.66 | -314.08 | 857.72 | 1,762 | 1,171 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | 43.52 | Upgrade |
Loss (Gain) From Sale of Investments | -0.39 | - | - | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | 427.18 | 1,093 | 38.84 | 478.78 | 1,036 | 54.54 | Upgrade |
Other Operating Activities | 6,187 | -4,223 | 6,365 | 1,068 | -7,295 | -99.56 | Upgrade |
Change in Accounts Receivable | -26,809 | 12,318 | -31,371 | 271.53 | -12,868 | 1,258 | Upgrade |
Change in Inventory | -3,855 | 5,124 | 1,801 | -1,803 | -1,399 | -5,606 | Upgrade |
Change in Accounts Payable | 5,011 | -19,141 | 15,056 | 61.24 | -9,062 | 3,260 | Upgrade |
Change in Other Net Operating Assets | 10,294 | -5,983 | 3,929 | -2,987 | 1,662 | -302.78 | Upgrade |
Operating Cash Flow | 21,917 | 13,921 | 20,640 | 9,562 | -6,864 | 7,298 | Upgrade |
Operating Cash Flow Growth | 359.31% | -32.55% | 115.86% | - | - | -39.76% | Upgrade |
Capital Expenditures | -6,122 | -5,372 | -2,580 | -4,099 | -2,368 | -3,977 | Upgrade |
Sale of Property, Plant & Equipment | 72.33 | 16.85 | 1,331 | 34.9 | 186.56 | 612.06 | Upgrade |
Sale (Purchase) of Intangibles | -65.9 | -74.08 | -22.34 | -126.73 | -111.07 | -7.93 | Upgrade |
Investment in Securities | -3,513 | -2,940 | -6,447 | -0.57 | -3.66 | -19.62 | Upgrade |
Other Investing Activities | 776.01 | -65.87 | -27.29 | 15.2 | 92.25 | 8,655 | Upgrade |
Investing Cash Flow | -8,853 | -8,435 | -7,746 | -4,176 | -2,204 | 5,262 | Upgrade |
Short-Term Debt Issued | - | 15,735 | 1,559 | - | - | - | Upgrade |
Long-Term Debt Issued | - | - | - | - | 11,757 | 17,745 | Upgrade |
Total Debt Issued | 1,494 | 15,735 | 1,559 | - | 11,757 | 17,745 | Upgrade |
Short-Term Debt Repaid | - | - | -3,210 | -2,293 | - | - | Upgrade |
Long-Term Debt Repaid | - | -2,432 | -11,016 | -1,378 | -4,886 | -24,343 | Upgrade |
Total Debt Repaid | -4,658 | -2,432 | -14,226 | -3,672 | -4,886 | -24,343 | Upgrade |
Net Debt Issued (Repaid) | -3,164 | 13,303 | -12,668 | -3,672 | 6,871 | -6,597 | Upgrade |
Dividends Paid | -2,174 | -2,190 | - | - | - | - | Upgrade |
Other Financing Activities | -310.43 | 0 | - | - | 0 | -859.72 | Upgrade |
Financing Cash Flow | -5,649 | 11,112 | -12,668 | -3,672 | 6,871 | -7,457 | Upgrade |
Foreign Exchange Rate Adjustments | -957.16 | -1,510 | -109.69 | -103.65 | -111.55 | 57.12 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | -0 | Upgrade |
Net Cash Flow | 6,459 | 15,089 | 116.21 | 1,610 | -2,308 | 5,161 | Upgrade |
Free Cash Flow | 15,795 | 8,549 | 18,060 | 5,462 | -9,232 | 3,321 | Upgrade |
Free Cash Flow Growth | - | -52.66% | 230.61% | - | - | -53.99% | Upgrade |
Free Cash Flow Margin | 6.97% | 4.69% | 8.73% | 3.60% | -5.74% | 2.42% | Upgrade |
Free Cash Flow Per Share | - | 430.32 | 908.99 | 274.94 | -464.68 | 167.17 | Upgrade |
Cash Interest Paid | 838.9 | 960.39 | 658.8 | 853.75 | 1,158 | 716.69 | Upgrade |
Cash Income Tax Paid | 5,064 | 9,491 | 3,183 | 834.52 | 2,927 | 2,638 | Upgrade |
Levered Free Cash Flow | 17,459 | -4,742 | 15,592 | 233.49 | -17,120 | 5,436 | Upgrade |
Unlevered Free Cash Flow | 18,183 | -4,175 | 16,028 | 844.34 | -16,657 | 6,046 | Upgrade |
Change in Working Capital | -15,360 | -7,682 | -10,586 | -4,457 | -21,668 | -1,391 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.